Medicine for blocking inflammation factors of patient suffering from articular cartilage injuries in knee arthritis
A technology for articular cartilage and knee arthritis, applied in the field of medicine and biology, can solve the problems of family and social burden and high operation cost
Inactive Publication Date: 2017-06-13
SHANDONG JINGYUAN BIOTECH CO LTD
View PDF6 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
For the elderly and patients with severe late symptoms and poor conservative treatment effect, artificial knee replacement is required. Not only the operation cost is high, it will cause serious burden to the patient, family and society, and a second operation is required
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0081] 1X10 7 cells / ml umbilical cord mesenchymal stem cells and 10 ng / ml superoxide dismutase and 5 ng / ml vitamin D.
Embodiment 2
[0083] 1X10 7 cells / ml umbilical cord mesenchymal stem cells and 15ng / ml superoxide dismutase and 8ng / ml vitamin D.
Embodiment 3
[0085] 1X10 7 cells / ml umbilical cord mesenchymal stem cells and 25ng / ml superoxide dismutase and 15ng / ml vitamin D.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention belongs to the technical field of medical biology and relates to a medicine for blocking inflammation factors of a patient suffering from articular cartilage injuries in knee arthritis. The medicine is characterized by being prepared from components as follows: 1*10<7> cell / ml umbilical cord mesenchymal stem cells, 10-25 ng / ml superoxide dismutase and 5-15 ng / ml vitamin D. The medicine is a novel medicine combination for treating Parkinson's disease clinically and can remarkably reduce the rising LDH level of lymphocyte of a Parkinson patient. The umbilical cord mesenchymal stem cells, superoxide dismutase and vitamin D compound drugs can be used for treating articular cartilage injuries in knee arthritis and have a good effect.
Description
technical field [0001] The invention belongs to the technical field of medicine and biology, and relates to a novel medicine for blocking inflammatory factors in patients with articular cartilage damage caused by knee arthritis by using umbilical cord mesenchymal stem cells, superoxide dismutase and vitamin D compound medicine. Background technique [0002] Articular cartilage damage in knee arthritis is more likely to occur in middle-aged and elderly people and people engaged in heavy-duty sports. The clinical manifestations are mainly two aspects: joint pain and motor dysfunction. At present, the clinical treatment effect is not good, mainly to relieve the pain of patients and improve the function of the knee joint. The reason is that the pathogenesis of cartilage damage in knee arthritis is not clear. Drug therapy is mainly symptomatic treatment, which temporarily relieves the pain of the patient, but the long-term effect is not good, and the symptoms are prone to repeate...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): A61K38/44A61P19/02A61P29/00A61K35/28A61K31/59
CPCA61K38/446A61K9/0014A61K31/59A61K35/28C12Y115/01001A61K2300/00
Inventor 崔超罗光会杨继建田丽娜
Owner SHANDONG JINGYUAN BIOTECH CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com